C.S. Kwon

529 total citations
21 papers, 360 citations indexed

About

C.S. Kwon is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, C.S. Kwon has authored 21 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 4 papers in Genetics and 3 papers in Surgery. Recurrent topics in C.S. Kwon's work include Platelet Disorders and Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Diabetes Treatment and Management (3 papers). C.S. Kwon is often cited by papers focused on Platelet Disorders and Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Diabetes Treatment and Management (3 papers). C.S. Kwon collaborates with scholars based in United States, Canada and United Kingdom. C.S. Kwon's co-authors include Peter M. Farrell, Anna Forsythe, Patrick Daniele, Christopher Ngai, Elizabeth T. Masters, Enrique Seoane‐Vazquez, Rosa Rodríguez-Monguió, Lauren J. Lee, Carla Mamolo and Ira Jacobs and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and BMC Health Services Research.

In The Last Decade

C.S. Kwon

19 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.S. Kwon United States 10 90 78 72 61 59 21 360
Eujin Park South Korea 14 227 2.5× 47 0.6× 20 0.3× 81 1.3× 60 1.0× 61 575
Eija Tukiainen Finland 10 38 0.4× 164 2.1× 75 1.0× 25 0.4× 27 0.5× 19 360
R Floris France 8 35 0.4× 91 1.2× 15 0.2× 78 1.3× 71 1.2× 29 314
Hélène Lazareth France 12 129 1.4× 71 0.9× 14 0.2× 13 0.2× 14 0.2× 36 370
Takahiko Ogawa Japan 12 151 1.7× 98 1.3× 15 0.2× 23 0.4× 23 0.4× 28 384
S Costantini Italy 9 49 0.5× 33 0.4× 17 0.2× 43 0.7× 23 0.4× 19 379
Cyril Cyrus Saudi Arabia 12 97 1.1× 59 0.8× 4 0.1× 61 1.0× 72 1.2× 42 396
Yoshitaka Koshino Japan 8 39 0.4× 20 0.3× 19 0.3× 19 0.3× 36 0.6× 28 333
Fengfeng Xu China 9 138 1.5× 81 1.0× 9 0.1× 18 0.3× 12 0.2× 11 416
Dhruti P. Chen United States 6 88 1.0× 76 1.0× 9 0.1× 20 0.3× 13 0.2× 11 361

Countries citing papers authored by C.S. Kwon

Since Specialization
Citations

This map shows the geographic impact of C.S. Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.S. Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.S. Kwon more than expected).

Fields of papers citing papers by C.S. Kwon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.S. Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.S. Kwon. The network helps show where C.S. Kwon may publish in the future.

Co-authorship network of co-authors of C.S. Kwon

This figure shows the co-authorship network connecting the top 25 collaborators of C.S. Kwon. A scholar is included among the top collaborators of C.S. Kwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.S. Kwon. C.S. Kwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mathew, Brian, Leah J. Blank, Edward M. Gotlieb, et al.. (2024). Health care access, psychosocial outcomes and mental health in adults living with epilepsy during the COVID-19 pandemic. Epilepsy & Behavior. 151. 109617–109617. 1 indexed citations
2.
Panaccione, Remo, Eric B. Collins, Gil Melmed, et al.. (2023). Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis. Crohn s & Colitis 360. 5(2). otad009–otad009. 37 indexed citations
3.
4.
Kwon, C.S., et al.. (2022). Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR). SHILAP Revista de lepidopterología. 20 indexed citations
5.
Kwon, C.S., Huamao Mark Lin, Eric N. Churchill, et al.. (2022). Non-small cell lung cancer with EGFR exon 20 insertion mutation: a systematic literature review and meta-analysis of patient outcomes. Current Medical Research and Opinion. 38(8). 1341–1350. 24 indexed citations
6.
Kwon, C.S., Patrick Daniele, Anna Forsythe, & Christopher Ngai. (2021). A Systematic Literature Review of the Epidemiology, Health-Related Quality of Life Impact, and Economic Burden of Immunoglobulin A Nephropathy. Journal of health economics and outcomes research. 8(2). 36–45. 29 indexed citations
7.
Kwon, C.S., Patrick Daniele, Anna Forsythe, & Christopher Ngai. (2021). A Systematic Literature Review of the Epidemiology, Health-Related Quality of Life Impact, and Economic Burden of Immunoglobulin A Nephropathy. Journal of health economics and outcomes research. 8(2). 36–45. 30 indexed citations
8.
Lee, Lauren J., C.S. Kwon, Anna Forsythe, et al.. (2020). <p>Humanistic and Economic Burden of Non-Muscle Invasive Bladder Cancer: Results of Two Systematic Literature Reviews</p>. ClinicoEconomics and Outcomes Research. Volume 12. 693–709. 32 indexed citations
9.
Forsythe, Anna, et al.. (2019). Health-related quality of life in acute myeloid leukemia patients not eligible for intensive chemotherapy: results of a systematic literature review. ClinicoEconomics and Outcomes Research. Volume 11. 87–98. 13 indexed citations
10.
Kwon, C.S., Enrique Seoane‐Vazquez, & Rosa Rodríguez-Monguió. (2018). Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes. BMC Health Services Research. 18(1). 78–78. 22 indexed citations
11.
Roy, Anuja, Menaka Bhor, Jaclyn Hearnden, et al.. (2018). A decision framework for treating chronic immune thrombocytopenia with thrombopoietin receptor agonists. Journal of Comparative Effectiveness Research. 7(8). 775–784. 2 indexed citations
12.
13.
14.
15.
16.
Kwon, C.S., Enrique Seoane‐Vazquez, & Rosa Rodríguez-Monguió. (2017). FDA safety actions for antidiabetic drugs marketed in the US, 1980–2015. International Journal of Risk & Safety in Medicine. 28(4). 197–211. 1 indexed citations
17.
Kwon, C.S., Enrique Seoane‐Vazquez, & Rosa Rodríguez-Monguió. (2016). COST-EFFECTIVENESS ANALYSIS OF PHARMACOLOGICAL TREATMENT PATHWAYS FOR TYPE 2 DIABETES DRUGS. Value in Health. 19(3). A202–A202.
18.
Kwon, C.S., et al.. (2005). Screening of Thrombin Inhibitors from Medicinal and Wild Plants. Korean Journal of Pharmacognosy. 35(1). 52–61. 5 indexed citations
19.
Abramov, Yoram, et al.. (2005). Site-Specific Rectocele Repair Compared With Standard Posterior Colporrhaphy. Obstetrical & Gynecological Survey. 60(5). 297–298. 3 indexed citations
20.
Kwon, C.S. & Peter M. Farrell. (2000). The Magnitude and Challenge of False-Positive Newborn Screening Test Results. Archives of Pediatrics and Adolescent Medicine. 154(7). 714–714. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eujin Park Breakdown of academic impact, for papers by Eija Tukiainen Breakdown of academic impact, for papers by R Floris Breakdown of academic impact, for papers by Hélène Lazareth Breakdown of academic impact, for papers by Takahiko Ogawa Breakdown of academic impact, for papers by S Costantini Breakdown of academic impact, for papers by Cyril Cyrus Breakdown of academic impact, for papers by Yoshitaka Koshino Breakdown of academic impact, for papers by Fengfeng Xu Breakdown of academic impact, for papers by Dhruti P. Chen
Rankless by CCL
2026